Status:
UNKNOWN
Clinical Effectiveness of First Trimester Pre-eclampsia Screening Program.
Lead Sponsor:
Far Eastern Memorial Hospital
Collaborating Sponsors:
Gynecologic Oncology Group
Conditions:
Pre-eclampsia
Eligibility:
FEMALE
20+ years
Brief Summary
To evaluate the clinical effectiveness of this screening program in preventing pre-eclampsia.
Detailed Description
The incidence of pre-eclampsia is about 2-8%, it is a leading cause of maternal and perinatal mortality and morbidity. Both ACOG (American Congress of Obstetricians and Gynecologists) and NICE (Nation...
Eligibility Criteria
Inclusion
- \- Women who are 20 years of age or older with singleton pregnancy between 11 to 13 + 6 weeks and received first trimester pre-eclampsia screening test in this institution.
Exclusion
- Women who are not regularly inspected or not receiving prenatal care in this institution.
- Women who received first trimester pre-eclampsia screening test at other institution
Key Trial Info
Start Date :
June 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 20 2025
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04021680
Start Date
June 10 2019
End Date
June 20 2025
Last Update
March 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banqiao District, New Taipei, Taiwan, 22050